Tech Company Financing Transactions
Affymax Funding Round
On 4/13/2004, Affymax raised $20 million in Series C funding from Bear Stearns Health Innoventures, Apax Partners and MPM Capital.
Transaction Overview
Company Name
Announced On
4/13/2004
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Bear Stearns Health Innoventures (Lead Investor) (Elizabeth Czerepak)
Proceeds Purpose
This financing allows us to aggressively pursue our clinical development plan for it and to continue to rapidly develop other peptides with more superior product profiles than recombinant proteins that address intractable diseases.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
19200 Stevens Creek Blvd. 240
Cupertino, CA 95014
USA
Cupertino, CA 95014
USA
Phone
Website
Email Address
Overview
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Mark Thompson
VP - Finance
Karin Walker
VP - General Counsel
Tracy Dunn
Browse more venture capital transactions:
Prev: 4/13/2004: Lancope venture capital transaction
Next: 4/13/2004: Website Pros venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs